{
    "Trade/Device Name(s)": [
        "VITROS Immunodiagnostic Products Total \u03b2-hCG II Reagent Pack",
        "VITROS Total \u03b2-hCG II Reagent Pack"
    ],
    "Submitter Information": "Ortho Clinical Diagnostics",
    "510(k) Number": "K233581",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063720"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA"
    ],
    "Summary Letter Date": "May 8, 2024",
    "Summary Letter Received Date": "March 26, 2024",
    "Submission Date": "March 26, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)",
        "hCG \u03b2-subunit"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (Heparin)",
        "Plasma (EDTA)"
    ],
    "Specimen Container(s)": [
        "Lithium-Heparin tube",
        "K2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunometric immunoassay",
        "Chemiluminescent detection (luminol)"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Immunodiagnostic Products Total \u03b2-hCG II Reagent Pack for quantitative measurement of hCG and its \u03b2-subunit in serum and plasma on VITROS 5600 Integrated System",
    "Indications for Use Summary": "For the quantitative measurement of human chorionic gonadotropin (hCG) and its \u03b2-subunit in human serum and plasma (heparin and EDTA) using the VITROS 5600 Integrated System to aid in the early detection of pregnancy.",
    "fda_folder": "Clinical Chemistry"
}